A71T (p.Ala71Thr) variant of CDX2 (Homeobox protein CDX-2)
A71T (p.Ala71Thr) in CDX2 (Homeobox protein CDX-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data.
A71T (p.Ala71Thr) variant details
- p.Ala71Thr
- NCI-TCGA TCGA novel
- TOPMed rs938780507
- gnomAD rs938780507
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.293
- REVEL 0.11
- MetaLR 0.06
- MetaSVM -1.00
- CADD 18.50
- PolyPhen-2 0.23
- SIFT 0.10
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 0.00047)